Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms
Ning Yi Yap, Retnagowri Rajandram, Keng Lim Ng, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-22
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
Qingquan Zeng, Shuolei Sun, Yaxian Li, et al.
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 87
Renal Cancer Stem Cells: Characterization and Targeted Therapies
Anna Julie Peired, Alessandro Sisti, Paola Romagnani
Stem Cells International (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 40
Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity
Daisuke Kiyozawa, Kenichi Kohashi, Dai Takamatsu, et al.
Human Pathology (2021) Vol. 112, pp. 48-58
Open Access | Times Cited: 30
Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype
Riuko Ohashi, Peter Schraml, Silvia Angori, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1492-1492
Open Access | Times Cited: 35
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients
Riuko Ohashi, Silvia Angori, Aashil A. Batavia, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 465-465
Open Access | Times Cited: 29
Chromosomal aberrations in renal cell carcinoma: An overview with implications for clinical practice
Ghulam Nabi, MuhammadBilal Quddus, Norman Pratt
Urology Annals (2019) Vol. 11, Iss. 1, pp. 6-6
Open Access | Times Cited: 23
Bioinformatics Analysis of the Prognostic and Biological Significance of ZDHHC-Protein Acyltransferases in Kidney Renal Clear Cell Carcinoma
Zhuang Liu, Chang Liu, Mingming Xiao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 20
Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma
Wassim Kassouf, Leonardo L. Monteiro, Darrel Drachenberg, et al.
Canadian Urological Association Journal (2018) Vol. 12, Iss. 8
Open Access | Times Cited: 18
Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma
Riuko Ohashi, Peter Schraml, Aashil A. Batavia, et al.
Translational Oncology (2019) Vol. 12, Iss. 9, pp. 1131-1137
Open Access | Times Cited: 16
Histologic re‑evaluation of a population‑based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification
Selena Odeh, Iryna Samarska, Andrés Matoso, et al.
Oncology Letters (2023) Vol. 25, Iss. 5
Open Access | Times Cited: 5
VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinoma
Pramod Mallikarjuna, Raviprakash T. Sitaram, Maréne Landström, et al.
Oncotarget (2018) Vol. 9, Iss. 23, pp. 16297-16310
Open Access | Times Cited: 15
Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment
Liang Zhu, Peixin Chen, Hao Wang, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 2, pp. 339-357
Open Access | Times Cited: 8
Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
Xiong Zou, Bingqian Guo, Ling Qiang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 8
Expression of HIF-α and their association with clinicopathological parameters in clinical renal cell carcinoma
Raviprakash T. Sitaram, Börje Ljungberg
Upsala Journal of Medical Sciences (2024) Vol. 129, pp. e9407-e9407
Open Access | Times Cited: 1
The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma
Richard Weiten, Tim Müller, Doris Schmidt, et al.
Cancer Biomarkers (2018) Vol. 21, Iss. 4, pp. 839-847
Closed Access | Times Cited: 11
Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis
Jingyuan Tang, Zhiqiang Qin, Xiao Li, et al.
Oncotarget (2017) Vol. 8, Iss. 30, pp. 50034-50050
Open Access | Times Cited: 10
Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
Peter J. Selby, Rosamonde E. Banks, Walter M. Gregory, et al.
Programme Grants for Applied Research (2018) Vol. 6, Iss. 3, pp. 1-528
Open Access | Times Cited: 10
DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma
Ming Li, Shengli Xia, Ping Shi
PeerJ (2020) Vol. 8, pp. e10307-e10307
Open Access | Times Cited: 9
A Neurosurgical Perspective on Brain Metastases from Renal Cell Carcinoma: Multi-Institutional, Retrospective Analysis
Liliana Eleonora Semenescu, Ligia Gabriela Tătăranu, Anica Dricu, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2485-2485
Open Access | Times Cited: 3
Biomarkers of Renal Cancer
Naveen Vasudev, Rosamonde E. Banks
Elsevier eBooks (2016), pp. 421-467
Closed Access | Times Cited: 6
Stem Cells Treatment to Combat Cancer and Genetic Disease: From Stem Cell Therapy to Gene-Editing Correction
Fakher Rahim, Babak Arjmand, Bagher Larijani, et al.
Stem cells in clinical applications (2018), pp. 29-59
Closed Access | Times Cited: 6
Renal Clear Cell Cancer
Rahul Arora, Faten Limaïem
StatPearls (2021)
Closed Access | Times Cited: 4
Radiogenomics Pilot Study: Association Between Radiomics and Single Nucleotide Polymorphism-Based Microarray Copy Number Variation in Diagnosing Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
Abeer J. Alhussaini, Abirami Veluchamy, Adel Jawli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12512-12512
Open Access
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma
Till Eichenauer, Navid Shadanpour, Martina Kluth, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Targeted Agents and Resistance Mechanism in Renal Cell Cancer
Shaghayegh Rezapourbehnagh, Arzu Yaşar, Çağatay Arslan, et al.
Bulletin of Urooncology (2019) Vol. 18, Iss. 2, pp. 73-79
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top